If you are searching for the “cost of tesofensine,” the honest answer is the one a buy guide will not give you: there is no legitimate price, because there is no legitimate product to sell. Tesofensine is an investigational triple monoamine reuptake inhibitor — it was developed by NeuroSearch and later carried forward by Saniona (studied combined with metoprolol as “Tesomet”) — and it is not approved by the FDA or marketed as a weight-loss drug anywhere in the United States.[1] That single fact governs everything below. A drug with no approval has no pharmacy shelf, no insurance code, and no retail price. The only numbers you will find attached to it come from the gray market, and this page exists to explain what those numbers actually buy — and what to do instead.
Why no approved price exists
A retail price is the last link in a long chain of accountability, not the first. When a medicine has a price at a pharmacy, it has already cleared human trials for a defined use, is manufactured under current Good Manufacturing Practice so the milligrams per dose are verified lot to lot, and sits inside a system of prescriptions, labels, and recalls. Tesofensine has done none of that. It remains investigational: its headline evidence is a single Phase 2 obesity trial (TIPO-1) that reported roughly 9.2% weight loss at the 0.5 mg dose over 24 weeks — a striking number, but one that later drew a journal Expression of Concern and was never confirmed in a completed Phase 3.[1] We walk through that whole record, and its big asterisk, in our tesofensine evidence review. A compound at that stage cannot be legally prescribed or sold for human use, which is precisely why it has no price you can trust. The absence of a number here is the finding, not a gap in our research.
The only “pricing” that circulates
Search hard enough and you will find tesofensine listed by “research chemical” and peptide vendors, often at what looks like a modest per-vial or per-milligram cost. It is worth being precise about what that price tag represents. The “research use only” label is a legal disclaimer that lets a seller sidestep drug regulation while implicitly selling for human use — it is a marketing line, not an assay. The product is not manufactured, tested, or labeled for human use, and buying, importing, or using an unapproved drug this way sits outside the law. This section is a warning, not a buying guide.
- Unknown purity and potency. Without verified manufacturing, the amount of actual tesofensine in the vial — if any — is unknown. Independent analyses of compounds bought online routinely find products that are under-dosed, over-dosed, or mislabeled, so the “dose” you pay for may not be the dose you receive.
- Contamination and no sterility. Non-pharmaceutical production can leave bacterial endotoxin, heavy metals, residual solvents, or synthesis by-products behind, and nothing about a gray-market vial guarantees it is sterile.
- No dose control on a stimulant-class drug. Tesofensine is not a benign supplement. In its trials it behaved like the monoamine-raising drug it is — raising heart rate, which is exactly why the later Tesomet program paired it with a beta-blocker.[2] Self-dosing an unknown concentration of a cardioactive drug, with no one monitoring you, is the risk the low price hides.
- Legal exposure. An unapproved drug purchased for human use is not a regulated transaction; there is no recourse if the product is wrong, and possession or import can itself be unlawful.
Where development actually stands (2026)
None of the above is offset by an imminent approval. As of 2026, tesofensine’s human evidence base is still the flagged Phase 2 obesity trial plus a small randomized trial of Tesomet (tesofensine + metoprolol) in the niche condition of hypothalamic obesity, which reported about 6.3% additional weight loss over 24 weeks and was designed with the beta-blocker specifically to blunt the drug’s cardiovascular effects.[2] There is no completed, confirming Phase 3 obesity trial and no FDA approval,[1] so there is no near-term path by which a legitimate, priced product appears at a US pharmacy. Anyone selling it today is operating well ahead of the science, and charging you for the privilege.
If what you want is weight-loss treatment you can price
Most people searching “tesofensine cost” are not researchers — they want a weight-loss result at a price they can plan around. The responsible route to that is not an unregulated vial; it is an approved GLP-1 medicine. Semaglutide and tirzepatide have completed the trials tesofensine has not, are made to GMP standards, and are prescribed and transparently priced through licensed telehealth, with a clinician accountable for your care. They are not the same molecule, but they are real, studied, and obtainable — which tesofensine, for human use, is not. For how those options stack up on price, our guide to the cheapest legitimate tirzepatide is the honest place to start, and our roundup of peptides marketed for weight loss puts tesofensine in context against the compounds that actually have an approval and a price. If you are weighing an investigational drug purely because of a headline number, read why there is no legitimate place to buy retatrutide too — it is the same lesson in a different molecule.
The honest bottom line
“Tesofensine cost” has no legitimate answer, and a premium, evidence-first source should say so rather than quote a gray-market figure as if it were a real price. The drug is investigational and unapproved; the only numbers attached to it come from vendors selling an untested, non-sterile product it is not legal to use as a medicine; and its development record — one flagged Phase 2 trial, no confirming Phase 3 — does not support human use at any price.[1][2] If you want the science, read the evidence review. If you want treatment you can actually price and be prescribed, talk to a licensed clinician about the approved GLP-1 options. What you should not do is pay for an unapproved drug from a website — the cheapest vial on the internet is still the most expensive way to get hurt.